APA (7th ed.) Citation

JT, P., P, L., IM, O., SE, D., RN, M., SR, K., . . . JK, B. (2022). Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies. Clinical pharmacology and therapeutics, 111(5), 1133. https://doi.org/10.1002/cpt.2559

Chicago Style (17th ed.) Citation

JT, Podichetty, Lang P, O'Doherty IM, David SE, Muse RN, Karpen SR, Song LS, Romero K, and Burton JK. "Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies." Clinical Pharmacology and Therapeutics 111, no. 5 (2022): 1133. https://doi.org/10.1002/cpt.2559.

MLA (9th ed.) Citation

JT, Podichetty, et al. "Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies." Clinical Pharmacology and Therapeutics, vol. 111, no. 5, 2022, p. 1133, https://doi.org/10.1002/cpt.2559.